Pan-cancer analysis reveals potential of FAM110A as a prognostic and immunological biomarker in human cancer

BACKGROUND: Despite great success, immunotherapy still faces many challenges in practical applications. It was previously found that family with sequence similarity 110 member A (FAM110A) participate in the regulation of the cell cycle and plays an oncogenic role in pancreatic cancer. However, the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Hongguang, Shi, Qianqian, Wen, Qin, Chen, Jingyi, Li, Xuan, Ruan, Ruiwen, Zeng, Shaocheng, Dai, Xiaofeng, Xiong, Jianping, Li, Li, Lei, Wan, Deng, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008925/
https://www.ncbi.nlm.nih.gov/pubmed/36923407
http://dx.doi.org/10.3389/fimmu.2023.1058627

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008925/
https://www.ncbi.nlm.nih.gov/pubmed/36923407
http://dx.doi.org/10.3389/fimmu.2023.1058627

Ejemplares similares